Kostaive: The Self-Amplifying mRNA Vaccine — Approved Without Safety Review
·1000 words·5 mins
There is one critical difference between a conventional mRNA vaccine and what the EU approved in February 2025.
A conventional mRNA vaccine delivers a blueprint into the body. The body produces the protein, the immune response is triggered, the blueprint is degraded.